2038 J ournal of Medicinal Chemistry, 1996, Vol. 39, No. 10
Guichard et al.
(23) Sette, A.; Alexander, J .; Ruppert, J .; Snoke, K.; Franco, A.;
Ishioka, G.; Grey, H. M. Antigen analogs/MHC complexes as
specific T cell receptor antagonists. Annu. Rev. Immunol. 1994,
12, 413-431.
(24) Karin, N.; Mitchell, D. N.; Brocke, S.; Ling, N.; Steinman, L.
Reversal of experimental autoimmune encephalomyelitis by a
soluble peptide variant of a myelin basic protein epitope: T cell
receptor antagonism and reduction of interferon γ and tumor
necrosis factor R production. J . Exp. Med. 1994, 180, 2227-2237.
(25) Kuchroo, V. K.; Greer, J . M.; Deepak, K.; Ishioka, G.; Franco,
A.; Sette, A.; Sobel, R. A.; Lees, M. B. A single TCR antagonist
peptide inhibits experimental allergic encephalomyelitis medi-
ated by a diverse T cell repertoire. J . Immunol. 1994, 153, 3326-
3336.
Refer en ces
(1) Townsend, A.; Bodmer, H. Antigen Recognition by class I-
restricted T lymphocytes. Annu. Rev. Immunol. 1989, 7, 601-
624.
(2) Falk, K.; Ro¨tzschke, O.; Stevanovic, S.; J ung, G.; Rammensee,
H.-G. Allele-specific motifs revealed by sequencing of self-
peptides eluted from MHC molecules. Nature 1991, 351, 290-
296.
(3) Bjorkman, P. J .; Saper, M. A.; Samraoui, B.; Bennett, W. S.;
Strominger, J . L.; Wiley, D. C. Structure of the human class I
histocompatibility antigen, HLA-A2. Nature 1987, 329, 506-
512. Bjorkman, P. J .; Saper, M. A.; Samraoui, B.; Bennett, W.
S.; Strominger, J . L.; Wiley, D. C. The foreign antigen binding
site and T cell recognition regions of class I histocompatibility
antigens. Nature 1987, 329, 512-518.
(26) J ameson, S. C.; Bevan, M. J . T cell receptor antagonists and
partial agonists. Immunity 1995, 2, 1-11.
(27) Lamont, A. G.; Powell, M. F., Colon, S. M.; Miles, C.; Grey, H.
M.; Sette, A. The use of peptide analogs with improved stability
and MHC binding capacity to inhibit antigen presentation in
vitro and in vivo. J . Immunol. 1990, 144, 2493-2498.
(28) Widmann, C.; Maryanski, J . L.; Romero, P.; Corradin, G.
Differential stability of antigenic MHC class I-restricted syn-
thetic peptides. J . Immunol. 1991, 147, 3745-3751.
(29) Chorev, M.; Shavitz, R.; Goodman, M.; Minick, S.; Guillemin,
R. Partially modified retro-inverso-enkephalinamides: Topochem-
ichal long-lasting analogs in vitro and in vivo. Science 1979, 204,
1210-1212.
(4) Madden, D. R.; Gorga, J . L.; Strominger, J . L.; Wiley, D. C.
Structure of HLA-B27 reveals nonamer self peptides bound in
an extended conformation. Nature 1991, 353, 321-325.
(5) Saper, M. A.; Bjorkman, P. J .; Wiley, D. C. Refined structure of
the human histocompatibility antigen HLA-A2 at 2.6 Å resolu-
tion. J . Mol. Biol. 1991, 219, 277-319.
(6) Silver, M. L.; Guo, H.-C.; Strominger, J . L.; Wiley, D. C. Atomic
structure of a human MHC molecule presenting an influenza
virus peptide. Nature 1992, 360, 367-369.
(7) Madden, D. R.; Gorga, J . L.; Strominger, J . L.; Wiley, D. C. The
three-dimentional structure of HLA-B27 at 2.1 Å resolution
suggests a general mechanism for tight peptide binding to MHC.
Cell 1992, 70, 1035-1048.
(8) Fremont, D. H.; Matsumura, M.; Stura, E. A.; Peterson, P. A.;
Wilson, I. A. Crystal structures of two viral peptides in complex
with murine MHC class I H-2Kb. Science 1992, 257, 919-927.
Matsumura, M.; Fremont, D. H.; Stura, E. A.; Peterson, P. A.;
Wilson, I. A. Emerging principles for the recognition of peptide
antigens by MHC Class I molecules. Science 1992, 257, 927-
934.
(30) Verdini, A. S.; Silvestri, S.; Becherucci, C.; Longobardi, M. G.;
Parente, L.; Peppoloni, S.; Perretti, M.; Pileri, P.; Pinori, M.;
Viscomi, G. C.; Nencioni, L. Immunostimulation by a partially
modified retro-inverso-tuftsin analogue containing Thr1
Ψ[NH-
CO](R,S)Lys2 modification. J . Med. Chem. 1991, 34, 3372-3379.
(31) Doulut, S.; Rodriguez, M.; Lugrin, D.; Vecchini, F.; Kitabgi, P.;
Aumelas, A.; Martinez, J . Reduced peptide bond pseudopeptide
analogues of neurotensin. Pept. Res. 1992, 5, 30-38.
(32) Chorev, M.; Goodman, M. A dozen years of retro-inverso pepti-
domimetics. Acc. Chem. Res. 1993, 26, 266-273.
(9) Madden, D. R.; Garboczi, D. N.; Wiley, D. C. The antigenic
(33) Martinez, J .; Bali, J . P.; Rodriguez, M.; Castro, B.; Magous, R.;
Laur, J .; Lignon, M. F. Synthesis and biological activities of some
pseudo-peptide analogues of tetragastrin: The importance of
peptide backbone. J . Med. Chem. 1985, 28, 1874-1879.
(34) Rodriguez, M.; Lignon, M. F.; Galas, M. C.; Fulcrand, P.; Mendre,
C.; Aumelas, A.; Laur, J .; Martinez, J . Synthesis and biological
activities of pseudopeptide analogues of the C-terminal hep-
tapeptide of cholecystokinin. On the importance of peptide bonds.
J . Med. Chem. 1987, 30, 1366-1373.
(35) Rodriguez, M.; Dubreuil, P.; Bali, J . P.; Martinez, J . Synthesis
and biological activity of partially modified retro-inverso
pseudopeptide derivatives of the C-terminal tetrapeptide of
gastrin. J . Med. Chem. 1987, 30, 758-763.
(36) Coy, D. H.; Taylor, J . E.; J iang, N. Y.; Kim, S. H.; Wang, L. H.;
Huang, S. C.; Moreau, J . P.; Gardner, J . D.; J ensen, R. T. Short-
chain pseudopeptide bombesin receptor antagonists with en-
hanced binding affinities for pancreatic acinar and swiss 3T3
cells display strong antimitotic activity. J . Biol. Chem. 1989, 264,
14691-14697.
(37) Schiller, P. W.; Weltrowska, G.; Nguyen, T. M. D.; Wilkes, B.
C.; Chung, N.; Lemieux, C. TIPP[Ψ]: a highly potent and stable
pseudopeptide δ opioid receptor antagonist with extraordinary
δ selectivity. J . Med. Chem. 1993, 36, 3182-3187.
(38) Leban, J . J .; Kull, F. C.; Landavazo, J . A.; Stocksstill, B.;
McDermed, J . D. Development of potent gastrin-releasing pep-
tide antagonists having a D-Pro-Ψ(CH2NH)-Phe-NH2 C termi-
nus. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 1922-1926.
(39) Guichard, G.; Benkirane, N.; Zeder-Lutz, G.; Van Regenmortel,
M. H. V.; Briand, J . P.; Muller, S. Antigenic mimicry of natural
L-peptides with retro-inverso-peptidomimetics. Proc. Natl. Acad.
Sci. U.S.A. 1994, 91, 9765-9769.
(40) Guichard, G.; Benkirane, N.; Muller, S.; Briand, J . P. Synthesis
and antigenic properties of reduced peptide bond pseudopeptide
analogues of a histone H3 hexapeptide. Pept. Res. 1994, 7, 308-
321.
(41) Benkirane, N.; Guichard, G.; Van Regenmortel, M. H. V.; Briand,
J . P.; Muller, S. Cross-reactivity of antibodies to retro-inverso
peptidomimetics with the parent protein histone H3 and chro-
matin core particle: Specificity and kinetic rate-constant mea-
surements. J . Biol. Chem. 1995, 270, 11921-11926.
(42) Muller, S.; Guichard, G.; Benkirane, N.; Brown, F.; Van Regen-
mortel, M. H. V.; Briand, J . P. Enhanced immunogenicity and
cross-reactivity of retro-inverso peptidomimetics of the major
antigenic site of foot-and-mouth disease virus. Pept. Res. 1995,
8, 138-144.
identity of peptide-MHC complexes:
conformations of five viral peptides presented by HLA-A2. Cell
1993, 75, 693-708.
A comparison of the
(10) Young, A. C. M.; Zhang, W.; Sacchettini, J . C.; Nathenson, S.
G. The three-dimentional structure of H-2Db at 2.4 Å resolu-
tion: implications for antigen-determinant selection. Cell 1994,
76, 39-50.
(11) Young, A. C. M.; Nathenson, S. G.; Sacchettini, J . C. Structural
studies of class I major histocompatibility complex proteins:
insights into antigen presentation. FASEB J . 1995, 9, 26-36.
(12) Parker, K. C.; Bednarek, M. A.; Hull, L. K.; Utz, U.; Cunning-
ham, B.; Zweerink, H. J .; Biddison, W. E.; Coligan, J . E.
Sequence motifs important for peptide binding to the human
MHC class I molecule, HLA-A2. J . Immunol. 1992, 149, 3580-
3587.
(13) Hunt, D. F.; Henderson, R. A.; Shabanowitz, J .; Sakaguchi, K.;
Michel, H.; Sevilir, N.; Cox, A. L.; Appella, E.; Engelhard, V. H.
Characterisation of peptides bound to the class I MHC molecule
HLA-A2.1 by mass spectroscopy. Science 1992, 255, 1261-1263.
(14) Appella, E.; Loftus, D. J .; Sakaguchi, K.; Sette, A.; Celis, E.
Synthetic antigenic peptides as a new strategy for immuno-
therapy of cancer. Biomed. Pept., Proteins Nucleic Acids 1995,
1, 177-184.
(15) Melief, C. J . M.; Kast, M. T-cell immunotherapy of tumors by
adoptive transfer of cytotoxic T lymphocytes and by vaccination
with minimal essential epitopes. Immunol. Rev. 1995, 146, 167-
177.
(16) Guillet, J . G.; Lai, M.-Z.; Brinner, T.; Smith, J . A.; Gefter, M. L.
Interaction of peptide antigens and class II major histocompat-
ibility complex antigens. Nature 1986, 324, 260-262.
(17) Grey, H. M.; Sette, A.; Lamont, A. Biologic significance and
therapeutic implications of antigen-MHC interactions. Clin.
Immunol. Immunopathol. 1989, 53, S47-S52.
(18) Lamont, A. G.; Sette, A.; Fujinami, R.; Colon, S. M.; Miles, C.;
Grey, H. M. Inhibition of experimental autoimmune encepha-
lomyelitis induction in SJ L/J mice by using a peptide with high
affinity for IAs molecules. J . Immunol. 1990, 145, 1687-1693.
(19) De Magistris, M. T.; Alexander, J .; Coggeshall, M.; Altman, A.;
Gaeta, F. C. A.; Grey, H. M.; Sette, A. Antigen analog-major
histocompatibility complexes act as antagonists of the T cell
receptor. Cell 1992, 68, 625-634.
(20) J ameson, S. C.; Carbone, F. R.; Bevan, J . Clone specific T cell
receptor antagonists of major histocompatibility complex class
I-restricted cytotoxic T cells. J . Exp. Med. 1993, 177, 1541-1550.
(21) Bertoletti, A.; Sette, A.; Chisari, F. V.; Penna, A.; Levrero, M.;
DeCarli, M.; Fiaccadori, F.; Ferrari, C. Natural variants of
cytotoxic epitopes are T-cell receptor antagonists for antiviral
cytotoxic T cells. Nature 1994, 369, 407-410.
(22) Sloan-Lancaster, J .; Allen, P. M. Significance of T-cell stimula-
tion by altered peptide ligands in T cell biology. Curr. Opin.
Immunol. 1995, 7, 103-109.
(43) Briand, J . P.; Guichard, G.; Dumortier, H.; Muller, S. Retro-
inverso peptidomimetics as new immunological probes: valida-
tion and application to the detection of antibodies in rheumatic
diseases. J . Biol. Chem. 1995, 270, 20686-20691.
(44) Du¨rr, H.; Goodman, M.; Gu¨nther, J . Retro-inverso amide bonds
between trifunctional amino acids. Angew. Chem., Int. Ed. Engl.
1992, 31, 785-787.